Abbott Laboratories (ABT) was upgraded today by Deutsche Bank (DB) from hold to buy with a price target of $70, as the firm believes that the recent split will be beneficial to the share price. Shares are higher by about 1.4 percent.
Abbott Laboratories (ABT) was upgraded today by Deutsche Bank (DB) from hold to buy with a price target of $70, as the firm believes that the recent split will be beneficial to the share price. Shares are higher by about 1.4 percent.
